Valuation: AcuCort AB

Market Cap 115M 11.65M 10.18M 9.57M 8.73M 16.39M 1.11B 16.4M 44.33M 569M 43.76M 42.81M 1.83B P/E 2024
-3.61x
P/E 2025 -5x
Enterprise Value 87.87M 8.91M 7.79M 7.32M 6.68M 12.54M 852M 12.54M 33.91M 435M 33.47M 32.74M 1.4B EV / Sales 2024
129,716,884x
EV / Sales 2025 165,436,272x
Free-Float
66.46%
Yield 2024 *
-
Yield 2025 -
1 day-0.20%
1 week-10.91%
Current month-18.33%
1 month-9.93%
3 months+8.65%
6 months-15.37%
Current year-18.33%
1 week 0.48
Extreme 0.485
0.55
1 month 0.48
Extreme 0.485
0.66
Current year 0.4
Extreme 0.401
0.95
1 year 0.4
Extreme 0.401
0.95
3 years 0.33
Extreme 0.327
1.26
5 years 0.33
Extreme 0.327
4.42
10 years 0.33
Extreme 0.327
9.5
Manager TitleAgeSince
Chief Executive Officer 55 09/08/2020
Corporate Officer/Principal 53 14/10/2025
Director TitleAgeSince
Director/Board Member 68 08/02/2017
Chairman 63 01/01/2018
Director/Board Member 79 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%-10.91%-7.72%-13.12% 11.7M
-0.61%+3.79%-47.54%-10.04% 14.77B
-1.02%-1.23%-16.86%-4.16% 6.32B
-2.90%-5.17%-57.15%-36.78% 6.04B
+0.23%-2.03%-11.97%-24.58% 4.01B
-1.67%+0.61%-19.12%-37.40% 3.21B
-1.11%-2.74%+2.36%-31.01% 3.05B
+1.15%+10.89%-43.30%-20.32% 2.97B
+1.15%-6.94%+76.21% - 2.8B
-0.21%-3.27%-22.02%-10.64% 2.38B
Average -0.52%+0.10%-14.71%-20.89% 4.56B
Weighted average by Cap. -0.76%+1.40%-26.87%-18.61%

Financials

2024 2025
Net sales 0.68 0.07 0.06 0.06 0.05 0.1 6.55 0.1 0.26 3.34 0.26 0.25 10.78 0.69 0.07 0.06 0.06 0.05 0.1 6.66 0.1 0.27 3.4 0.26 0.26 10.97
Net income -17.4M -1.76M -1.54M -1.45M -1.32M -2.48M -169M -2.48M -6.71M -86.16M -6.63M -6.48M -278M -26.19M -2.66M -2.32M -2.18M -1.99M -3.74M -254M -3.74M -10.11M -130M -9.98M -9.76M -418M
Net Debt -2.77M -281K -246K -231K -211K -396K -26.88M -396K -1.07M -13.73M -1.06M -1.03M -44.26M -27.01M -2.74M -2.39M -2.25M -2.05M -3.85M -262M -3.86M -10.42M -134M -10.29M -10.07M -431M
Logo AcuCort AB
AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
Employees
-
Date Price Change Volume
22/09/26 SEK 0.4900 -0.20% 82,987
21/09/26 SEK 0.4910 -7.36% 208,932
18/09/26 SEK 0.5300 +2.71% 35,784
17/09/26 SEK 0.5160 +2.79% 173,213
16/09/26 SEK 0.5020 -5.99% 261,640
  1. Stock Market
  2. Stocks
  3. ACUC Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!